Large U.S. COVID-19 vaccine trials will exclude pregnant women for now  National PostView Full coverage on Google News

Large U.S. COVID-19 vaccine trials will exclude pregnant women for now | National Post

Who gets priority access to a vaccine? Should the first vaccines go to the most vulnerable and elderly populations? How do we define these terms? Who ...Who gets priority access to a vaccine? Should the first vaccines go to the most vulnerable and elderly populations? How do we define these terms? Who ...

Here are the COVID-19 vaccine prospects that have made it to phase three trials and beyond.Here are the COVID-19 vaccine prospects that have made it to phase three trials and beyond.

Dozens of COVID-19 vaccines are in development. Here are the ones to follow.

Watch Coronavirus: Trump looking at using military to distribute COVID-19 vaccine Video Online, on GlobalNews.caWatch Coronavirus: Trump looking at using military to distribute COVID-19 vaccine Video Online, on GlobalNews.ca

Coronavirus: Trump looking at using military to distribute COVID-19 vaccine | Watch News Videos Online

The federal government is not requiring basic demographic information to be collected during a clinical trial.The federal government is not requiring basic demographic information to be collected during a clinical trial.

How to prevent racial and ethnic disparities with a COVID-19 vaccine | TheHill

The federal government is not requiring basic demographic information to be collected during a clinical trial.The federal government is not requiring basic demographic information to be collected during a clinical trial.

How to prevent racial and ethnic disparities with a COVID-19 vaccine | TheHill

The COVAX scheme that aims to ensure poorer nations will have access to a Covid-19 vaccine when it arrives is already being undermined by rich Western nations ordering hundreds of millions of doses in an “us first” strategy.The COVAX scheme that aims to ensure poorer nations will have access to a Covid-19 vaccine when it arrives is already being undermined by rich Western nations ordering hundreds of millions of doses in an “us first” strategy.

Vaccine nationalism: Rich nations spend BILLIONS to grab first anti-coronavirus doses while poor countries are left behind (again) — RT Op-ed

Even if an effective Covid vaccine is licensed, the manufacturing of doses for administration to world’s population will need collaboration among manufactures.Even if an effective Covid vaccine is licensed, the manufacturing of doses for administration to world’s population will need collaboration among manufactures.

Why in this race to Covid-19 vaccine the world will need more than one winner

Even if an effective Covid vaccine is licensed, the manufacturing of doses for administration to world’s population will need collaboration among manufactures.Even if an effective Covid vaccine is licensed, the manufacturing of doses for administration to world’s population will need collaboration among manufactures.

Why in this race to Covid-19 vaccine the world will need more than one winner

COVID-19 vaccine cold war! - The Peninsula Qatar

It's dog eat dog in the world of COVID-19 vaccines.It's dog eat dog in the world of COVID-19 vaccines.

'Vaccine nationalism': Is it every country for itself? - Reuters

India News: A subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (SIndia News: A subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (S

Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine candidate | India News - Times of India

The coronavirus stories Medscape''s editors around the globe think you need to know about today.The coronavirus stories Medscape''s editors around the globe think you need to know about today.

COVID-19 Update: PPI Risk, Aerosol Transmission

Pharmaceutical company AstraZeneca repeated its promise not to profit from a COVID-19 vaccine during the pandemic as it reported it was on track with late-stage trials for the treatment.Pharmaceutical company AstraZeneca repeated its promise not to profit from a COVID-19 vaccine during the pandemic as it reported it was on track with late-stage trials for the treatment.

AstraZeneca: won't profit from COVID-19 vaccine in pandemic | CTV News

Even if some Americans opt out, the country will still reach herd immunity against COVID-19.Even if some Americans opt out, the country will still reach herd immunity against COVID-19.

People Are Suffering Too Much to Refuse a Vaccine - The Atlantic

WHO urges countries to support 'COVAX' vaccine scheme - The Jerusalem post

The coronavirus pandemic has been good news for investors in pharma companies racing to develop a Covid-19 vaccine. Stock prices for many of the competing companies are trading around record highs. Some examples: Moderna’s (NASDAQ: MRNA) value has jumped 4x from about $8 billion at the beginning...The coronavirus pandemic has been good news for investors in pharma companies racing to develop a Covid-19 vaccine. Stock prices for many of the competing companies are trading around record highs. Some examples: Moderna’s (NASDAQ: MRNA) value has jumped 4x from about $8 billion at the beginning...

Are Covid Vaccine Stocks Worth Investing In?

WASHINGTON, July 31 — The Trump administration anticipates launching a far-reaching promotions campaign by November to encourage Americans to get vaccinated against the coronavirus, contingent on evidence that a successful vaccine will be available roughly by year end, a senior administration...WASHINGTON, July 31 — The Trump administration anticipates launching a far-reaching promotions campaign by November to encourage Americans to get vaccinated against the coronavirus, contingent on evidence that a successful vaccine will be available roughly by year end, a senior administration...

US government to launch 'overwhelming' Covid-19 vaccine campaign by November | World | Malay Mail

Several coronavirus vaccine trials have reached the final Phase 3 stage of testing ahead of potential approvals from regulators. Researchers are targeting efficacy of at least 60% for the drugs, according to Dr. Anthony Fauci, which is the standard for vaccines.Several coronavirus vaccine trials have reached the final Phase 3 stage of testing ahead of potential approvals from regulators. Researchers are targeting efficacy of at least 60% for the drugs, ac…

This might be the best coronavirus vaccine news you’ve ever heard – BGR

Most viruses produce a long-lasting memory in a person’s immune system, but this is not always the case, says an observer.Most viruses produce a long-lasting memory in a person’s immune system, but this is not always the case, says an observer.

Commentary: Booster shots will likely be needed even if a COVID-19 vaccine is ready - CNA

Companies could struggle to enrol enough trial participants, or gather enough data to convince regulatory agencies that the shots work. Companies could struggle to enrol enough trial participants, or gather enough data to convince regulatory agencies that the shots work.Companies could struggle to enrol enough trial participants, or gather enough data to convince regulatory agencies that the shots work.

China’s coronavirus vaccines are leaping ahead – but face challenges as virus wanes

Coronavirus vaccine prices have been revealed or leaked for some of the companies at the forefront of COVID-19 vaccine research. Some pharmaceutical firms are looking to make a profit off of COVID-19 vaccines in the coming years.Coronavirus vaccine prices have been revealed or leaked for some of the companies at the forefront of COVID-19 vaccine research. Some pharmaceutical firms are looking to make a profit off of COVID-…

Here’s how much coronavirus vaccines might cost – BGR

AstraZeneca has struck a number of deals around the world to supply the experimental COVID-19 vaccine, which has shown promise in early testing.AstraZeneca has struck a number of deals around the world to supply the experimental COVID-19 vaccine, which has shown promise in early testing.

AstraZeneca: Won’t profit from COVID-19 vaccine in pandemic | coronavirus outbreak News,The Indian Express

A Covid-19 vaccine is coming soon, and when it does arrive, it will spark a huge, multi-quarter rebound in GE stock.A Covid-19 vaccine is coming soon, and when it does arrive, it will spark a huge, multi-quarter rebound in GE stock.

Here’s How GE Stock Could Almost Double in 18 Months | InvestorPlace

A Covid-19 vaccine is coming soon, and when it does arrive, it will spark a huge, multi-quarter rebound in GE stock.

Here’s How GE Stock Could Almost Double in 18 Months | InvestorPlace

SII had submitted a revised proposal on Wednesday after the expert panel had asked it to revise its protocol for the trials besides seeking some additional information

COVID-19 panel recommends DCGI to permit SII to conduct human trials of Oxford vaccine candidate - Express Pharma

The work to develop a Covid-19 vaccine has been impressive. But we don't need just any vaccine: we deserve one that's been proven to be safe and effective.The work to develop a Covid-19 vaccine has been impressive. But we don't need just any vaccine: we deserve one that's been proven to be safe and effective.

A Covid-19 vaccine, amazingly, is close. Why am I so worried? - STAT

Central Drugs Standard Control Organisation (CDSCO) has recommended the Drug Controller to grant permission to Serum Institute if India to begin the final phase of human trials for Covid vaccine CovishieldCentral Drugs Standard Control Organisation (CDSCO) has recommended the Drug Controller to grant permission to Serum Institute if India to begin the final phase of human trials for Covid vaccine Covishield

India Inches Closer Towards Oxford Vaccine, Panel Recommends DCGI To Permit SII For Human Trials

SAN ANTONIO - Mary Dixson is a wife, mother of two, a communications professor at UTSA and now the first person to get Pfizer's COVID-19 trial phase three vaccine in San Antonio. "I'm patient 001," Dixson said as she described feeling lucky being picked for the study. "I have friends and family who have had COVID and I've seen what it can do to people and of course I've seen what does to all of us in terms of changing our lives," Dickson explained as her motive for signing up.SAN ANTONIO - Mary Dixson is a wife, mother of two, a communications professor at UTSA and now the first person to get Pfizer's COVID-19 trial phase three vaccine in San Antonio. "I'm patient 001," Dixson said as she described feeling lucky being picked for the study. "I have friends and family who have had COVID and I've seen what it can do to people and of course I've seen what does to all of us in terms of changing our lives," Dickson explained as her motive for signing up.

"I'm lucky I was picked," said the first recipient of the COVID-19 trial vaccine in SA | WOAI

"I'm lucky I was picked," said the first recipient of the COVID-19 trial vaccine in SA

Here is a compilation of the COVID-19 vaccine candidates that are in phases 1-3.Here is a compilation of the COVID-19 vaccine candidates that are in phases 1-3.

The COVID-19 Live Vaccine Tracker

The concern is that vaccine supply and allocation in this coronavirus pandemic will echo the last - caused by the H1N1 flu virus in 2009/2010 - when rich nations bought up the available supply of vaccines, initially leaving poor countries with none.The concern is that vaccine supply and allocation in this coronavirus pandemic will echo the last - caused by the H1N1 flu virus in 2009/2010 - when rich nations bought up the available supply of vaccines, initially leaving poor countries with none.

‘Vaccine nationalism’: Is it every country for itself? | coronavirus outbreak News,The Indian Express

AstraZeneca has reported that it has obtained 'good data so far' on its Covid-19 vaccine candidate, which is currently in large-scale clinical studies.AstraZeneca has reported that it has obtained 'good data so far' on its Covid-19 vaccine candidate, which is currently in large-scale clinical studies.

AstraZeneca reports good progress of Covid-19 vaccine in trials

403 Forbidden

Human challenge trials and equitable distribution of vaccines were extensively discussed in this symposiumHuman challenge trials and equitable distribution of vaccines were extensively discussed in this symposium

Human Challenge Trial For COVID-19 Unnecessary: Anthony Fauci At ICMR Event

As medical professionals continue to work on a COVID-19 vaccine, one group is looking for adults of all races, ethnic groups, sexes and genders to volunteer for a clinical trial.As medical professionals continue to work on a COVID-19 vaccine, one group is looking for adults of all races, ethnic groups, sexes and genders to volunteer for a clinical trial.

COVID-19 Prevention Network seeking volunteers for vaccine clinical trial | abc7.com

Coronavirus vaccine news update: Biocon founder Kiran Mazumdar-Shaw said that the first doses of the vaccine should be administered to young people and health workersCoronavirus vaccine news update: Biocon founder Kiran Mazumdar-Shaw said that the first doses of the vaccine should be administered to young people and health workers

Coronavirus vaccine update: Eyes on India as candidates race towards finish line

Tune in to the Coronavirus Essential podcast with Sakshi Batra for all the top updates on the ongoing pandemic.Tune in to the Coronavirus Essential podcast with Sakshi Batra for all the top updates on the ongoing pandemic.

Coronavirus Essential podcast | Health ministry aims to conduct 10 lakh tests per day; Oxford vaccine showing good progress, says AstraZeneca - Moneycontrol.com

As the world inches closer to a coronavirus vaccine, it is also important to note that we may need more than one dose of the vaccine to battle against the novel contagion.As the world inches closer to a coronavirus vaccine, it is also important to note that we may need more than one dose of the vaccine to battle against the novel contagion.

Coronavirus vaccine update: We may need a booster shot for COVID-19 vaccine; here’s what it means | The Times of India

Right now, too many don't. The former head of immunization at the CDC explains why vaccine hesitancy has become a serious problem. Right now, too many don't. The former head of immunization at the CDC explains why vaccine hesitancy has become a serious problem.

How Americans Became Hesitant About Covid-19 Vaccines: A Q&A With Walter Orenstein - Barron's

The researchers from National Institute of Allergy and Infectious Diseases in the US and the Oxford University found that the ChAdOx1 nCoV-19 vaccine protects the macaques from COVID-19 pneumonia.The researchers from National Institute of Allergy and Infectious Diseases in the US and the Oxford University found that the ChAdOx1 nCoV-19 vaccine protects the macaques from COVID-19 pneumonia.

Oxford Vaccine Shows Protection Against Covid-19 in Monkeys: Study

Tens of millions of children are going without life-saving vaccines because the coronavirus pandemic has disrupted immunisation programmes across the world.Health chiefs fear that the decline inTens of millions of children are going without life-saving vaccines because the coronavirus pandemic has disrupted immunisation programmes across the world.Health chiefs fear that the decline in